Kinkade, C. W., Castillo-Martin, M., Puzio-Kuter, A., Yan, J., Foster, T. H., Gao, H., . . . Abate-Shen, C. (2008). Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model. American Society for Clinical Investigation.
Chicago ZitierstilKinkade, Carolyn Waugh, et al. Targeting AKT/mTOR and ERK MAPK Signaling Inhibits Hormone-refractory Prostate Cancer in a Preclinical Mouse Model. American Society for Clinical Investigation, 2008.
MLA ZitierstilKinkade, Carolyn Waugh, et al. Targeting AKT/mTOR and ERK MAPK Signaling Inhibits Hormone-refractory Prostate Cancer in a Preclinical Mouse Model. American Society for Clinical Investigation, 2008.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.